Parkinsonism Associated with Carcinoma Ovary

CC BY-NC-ND 4.0 · Indian J Med Paediatr Oncol 2004; 25(02): 38-39
DOI: 10.1055/s-0041-1733074

Case Report

Ravindra Vottery

Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai-400012, India

,

Amita Maheshwari

Department of Sugical Oncology, Tata Memorial Hospital, Parel, Mumbai-400012, India

,

Purvish M Parikh

Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai-400012, India

,

Hemant B Tongaonkar

Department of Sugical Oncology, Tata Memorial Hospital, Parel, Mumbai-400012, India

,

Samir Shah

Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai-400012, India

,

Sudeep Gupta

Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai-400012, India

References
1 Hudson C N, Curling M. In: Hudson C N, Editor. Ovarian Cancer. Oxford University Press; 1985, p. 10-12.
2 Dalmau J, Graus F. Paraneoplastic Syndromes of Nervous System. In: Black P, Loeffler J S, Editors. Cancer of the Nervous System. Blackwell Science,1997, p. 674- 700.
3 Brown R H. Paraneoplastic Neurologic Syndromes. In: Fauci et al, Editors. Harrison’s Principles of Internal Medicine.14th ed. McGraw Hill;1998, p. 622-626.
4 Goldbe L I, Miller D C. Paraneoplastic degeneration of substantia nigra with dystonia and Parkinsonism. Mov Disord 1989; 4(2): 147-152.
5 Denison RS, Wang F, Becker NA, Schule B, KockN, Phillips LA et al. Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene 2003, 22: 8370-8378,